Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Head and Neck Neoplasms × Curcumin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 10 Prostatic Neoplasms 8 Colonic Neoplasms 7 Neoplasms 5 Colorectal Neoplasms 5 Multiple Myeloma 4 Smoldering Multiple Myeloma 3 Monoclonal Gammopathy of Undetermined Significance 3 Lung Neoplasms 3 Uterine Cervical Neoplasms 2 Uterine Cervical Dysplasia 2 Stomach Neoplasms 2 Radiodermatitis 2 Pain 2 Esophageal Neoplasms 2 Breast Carcinoma In Situ 2 Adenomatous Polyposis Coli 2 cyclopia sequence 1 Uterine Neoplasms 1 Tuberous Sclerosis 1 Thrombocythemia, Essential 1 Stomatitis 1 Sezary Syndrome 1 Seizures 1 Rectal Neoplasms 1 Psychological Well-Being 1 Prostate Cancer Metastatic Castration Resistant 1 Primary Myelofibrosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polycythemia Vera 1

Interventions

Cisplatin 121 Radiotherapy 106 Cetuximab 81 Docetaxel 57 Radiotherapy, Intensity-Modulated 50 Surveys and Questionnaires 40 Carboplatin 40 Paclitaxel 38 pembrolizumab 37 Fluorouracil 35 Radiation 27 Blood Specimen Collection 24 Drug Therapy 21 Nivolumab 18 Erlotinib Hydrochloride 17 Magnetic Resonance Spectroscopy 16 Surgical Procedures, Operative 15 Standard of Care 14 Pemetrexed 13 Everolimus 13 durvalumab 12 Immunohistochemistry 12 Gemcitabine 12 Radiosurgery 11 Low-Level Light Therapy 11 Bevacizumab 11 Amifostine 11 Exercise 10 Celecoxib 10 Capecitabine 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04208334 2023-03-28

CurChexia

Phramongkutklao College of Medicine and Hospital

Phase 2 Completed

Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡